Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease.

Similar Items

• Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease.
  by: Campbell, D, et al.
  Published: (2005)
• Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
  by: Campbell, D, et al.
  Published: (2005)
• Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease.
  by: Campbell, D, et al.
  Published: (2006)
• Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial
  by: Arima, H, et al.
  Published: (2010)
• Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease.
  by: Campbell, D, et al.
  Published: (2007)